Low, J., Bowie, M., Wertman, V., Baker, E., Mangoli, A., Gibson, E., … Ashley, D. (2023). STING EPIGENETIC SILENCING IN GBM: IMPLICATIONS FOR INFLAMING THE IMMUNE MICROENVIRONMENT AND DESIGNING COMBINATION THERAPIES. In NEURO-ONCOLOGY (Vol. 25).

Low, Justin, Michelle Bowie, Virginia Wertman, Eric Baker, Avani Mangoli, Emiley Gibson, Rodrigo de La Vega Gomar, et al. “STING EPIGENETIC SILENCING IN GBM: IMPLICATIONS FOR INFLAMING THE IMMUNE MICROENVIRONMENT AND DESIGNING COMBINATION THERAPIES.” In NEURO-ONCOLOGY, Vol. 25, 2023.

Low J, Bowie M, Wertman V, Baker E, Mangoli A, Gibson E, et al. STING EPIGENETIC SILENCING IN GBM: IMPLICATIONS FOR INFLAMING THE IMMUNE MICROENVIRONMENT AND DESIGNING COMBINATION THERAPIES. In: NEURO-ONCOLOGY. 2023.

Low, Justin, et al. “STING EPIGENETIC SILENCING IN GBM: IMPLICATIONS FOR INFLAMING THE IMMUNE MICROENVIRONMENT AND DESIGNING COMBINATION THERAPIES.” NEURO-ONCOLOGY, vol. 25, 2023.

Low J, Bowie M, Wertman V, Baker E, Mangoli A, Gibson E, Gomar RDLV, Stevenson K, Fuller R, Hostettler J, Brown M, Waitkus M, Reitman Z, Ashley D. STING EPIGENETIC SILENCING IN GBM: IMPLICATIONS FOR INFLAMING THE IMMUNE MICROENVIRONMENT AND DESIGNING COMBINATION THERAPIES. NEURO-ONCOLOGY. 2023.